U.S. Medical Equipment Stock News

NasdaqGS:AGYS
NasdaqGS:AGYSSoftware

Will Strong Q1 Results and Higher Guidance Change Agilysys' (AGYS) Operating Leverage Narrative?

Agilysys, Inc. reported past first-quarter 2026 results with revenue of US$87.68 million and net income of US$8.99 million, materially higher than a year earlier, and raised its fiscal 2027 revenue and subscription growth guidance. The combination of stronger profitability and higher full-year subscription growth targets points to increasing operating leverage in Agilysys’ hospitality software model. Next, we’ll explore how this stronger quarter and higher full-year revenue outlook may...
NYSE:NEU
NYSE:NEUChemicals

Is NewMarket (NEU) Undervalued After Strong Second Quarter Earnings?

Why NewMarket earnings and buybacks matter for shareholders now NewMarket (NEU) just released second quarter 2026 results alongside a buyback progress update, providing fresh data on profitability, cash deployment, and how management is handling capital returns. The company reported second quarter sales of US$747.09 million and net income of US$133.75 million, with basic earnings per share from continuing operations of US$14.54. These figures sit alongside a completed multi year repurchase...
NYSE:PCG
NYSE:PCGElectric Utilities

PG&E (PCG) On Grid Investment Hopes And Why The Stock Still Looks Discounted

PG&E stock moves after recent performance shift PG&E (PCG) has drawn fresh attention after a recent shift in its share performance, with the stock closing at $17.46 on 6 August 2026. Investors are weighing this price against the company’s longer term returns and fundamentals. See our latest analysis for PG&E. PG&E’s recent 2.7% one-day share price return at $17.46 sits alongside a 90-day share price return of 7.7% and a one-year total shareholder return of 17.6%, suggesting momentum has been...
NYSE:AMT
NYSE:AMTSpecialized REITs

How Strong Q2 Results and Higher 2026 Guidance Could Shape American Tower (AMT) Investors

In the past quarter, American Tower Corporation reported second-quarter 2026 revenue of US$2,749.1 million and net income of US$867.5 million, both higher than a year earlier, and it revised its full-year 2026 guidance for total property revenue to US$10.70–US$10.85 billion and net income to US$3.27–US$3.35 billion. Alongside this earnings strength and higher guidance, the company continued its long-running share repurchase program, retiring about 3.19 million shares since 2017, which...
NasdaqCM:UROY
NasdaqCM:UROYMetals and Mining

Uranium Royalty (UROY) Reshapes Its Board As It Moves Past A Corporate Overhaul

Uranium Royalty (NasdaqCM:UROY) has appointed Kevin McQuilkin and Peter Rozenauers to its Board of Directors to support continued growth and oversee corporate transformation. The new directors bring experience across mining, finance, and resource management at a time when Uranium Royalty is working through recent restructuring steps. The Board refresh follows transformational corporate actions, including an SEC deregistration and a combination with Orion, and is intended to reinforce...
NasdaqGS:WYNN
NasdaqGS:WYNNHospitality

What Wynn Resorts (WYNN)'s Earnings Jump And $2.74 Billion Buyback Completion Mean For Shareholders

In early August 2026, Wynn Resorts reported second-quarter revenue of US$1,856.93 million and net income of US$140.06 million, alongside a US$0.25 per-share dividend and completion of a long-running US$2.74 billion share repurchase program. The combination of higher earnings per share from continuing operations and meaningful capital returns via dividends and buybacks highlights Wynn’s emphasis on strengthening shareholder value while it continues to invest in major projects like Wynn Al...
NYSE:LII
NYSE:LIIBuilding

Is Lennox (LII) Using Buybacks to Offset Weaker EPS Guidance or Reinforce Its Long-Term Play?

In the second quarter of 2026, Lennox International reported higher sales of US$1,545.3 million but essentially flat diluted EPS, while also completing a large share repurchase program totaling 16.72 million shares for US$3.45 billion since its October 2014 authorization. The company’s decision to slightly lower full‑year 2026 EPS guidance to US$23.00–US$24.00, despite reaffirming about 8% revenue growth aided by acquisitions, highlights the pressure from weaker residential demand even as...
NYSE:HAYW
NYSE:HAYWBuilding

Hayward Holdings (HAYW) Reaffirmed Guidance And Bought Back Shares, Is The Stock Still Cheap?

Hayward Holdings (HAYW) has caught investor attention after its late July 2026 update, which combined solid quarterly results, reaffirmed full year guidance, a completed debt refinancing, and an active share repurchase program. See our latest analysis for Hayward Holdings. Over the past year Hayward Holdings has seen a modest 1 year total shareholder return of 4.22%, while its 90 day share price return of 10.01% suggests momentum has picked up around the July earnings, refinancing, and...
NasdaqGS:ALKS
NasdaqGS:ALKSBiotechs

Did Alkermes’ (ALKS) Profit Slide and Cash-Conserving Moves Just Shift Its Investment Narrative?

Alkermes plc recently reported past second-quarter 2026 results, with revenue rising to US$496.01 million while net income fell sharply to US$0.50 million, and the company issued guidance calling for third-quarter 2026 revenue of US$450 million to US$470 million alongside an expected full-year 2026 GAAP net loss of US$95 million to US$115 million. At the same time, Alkermes paused buybacks after repurchasing 5.32% of its shares since 2024 and filed a US$311.11 million employee share plan...
OTCPK:FBAK
OTCPK:FBAKBanks

Did First National Bank Alaska’s (FBAK) Dividend and Earnings Update Just Recast Its Income-Focused Narrative?

First National Bank Alaska reported half-year 2026 results, posting net income of US$41.99 million, and in July its board declared a US$4.00 per-share cash dividend payable on September 15, 2026 to shareholders of record on September 1, 2026. This combination of solid profitability and continued cash returns to shareholders highlights the bank’s emphasis on income generation and capital return discipline. We will now examine how the affirmed US$4.00 dividend and recent earnings performance...
NasdaqGS:IEP
NasdaqGS:IEPIndustrials

Does Icahn Enterprises’ (IEP) Steady Payout Amid Quarterly Losses Reveal Its True Capital Priorities?

In August 2026, Icahn Enterprises reported second-quarter sales of US$3,081 million and revenue of US$2,975 million, alongside a net loss of US$348 million, and its board declared a US$0.50 quarterly distribution per depositary unit for holders of record on August 17, 2026, payable on or about September 23, 2026. The combination of higher year-on-year sales and revenue with a wider net loss, while maintaining a cash distribution, highlights the tension between Icahn Enterprises’ income...
NYSE:BDX
NYSE:BDXMedical Equipment

Becton Dickinson (BDX) Stock Still Looks Cheap After Its 19% Run

Becton Dickinson stock has delivered a 19.2% return over the past year, and the latest valuation work using a Discounted Cash Flow (DCF) intrinsic value estimate suggests the shares may still trade below that estimate by around 24.4%. At the same time, broad valuation checks point to a more mixed picture and standard earnings multiples look closer to fair value than outright cheap. Becton Dickinson’s 19.2% one year gain puts recent shareholders in profit, which raises the question of how...
NasdaqGS:FA
NasdaqGS:FAProfessional Services

First Advantage (FA) Stock May Be Below Fair Value After Raised Guidance

First Advantage stock has delivered a 73.8% return over the past three years, yet the valuation signals are split, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a large discount while traditional market multiples lean the other way. First Advantage's 73.8% three year return shows the stock has already rewarded shareholders and raises the bar for any further upside to be justified by fundamentals. Stronger demand for its screening and digital identity services can...
NasdaqGS:CROX
NasdaqGS:CROXLuxury

Crocs (CROX) Stock Still Looks Cheap Even After An 82% Run

Crocs stock has delivered a strong 81.6% return over the past year, yet the latest valuation checks still point to the shares trading below an estimate of intrinsic value based on a Discounted Cash Flow (DCF) model and market multiples. The 81.6% gain over the last 12 months suggests sentiment around Crocs has been positive, even with recent swings around company updates. Recent record revenue and changes to how marketplace sales are reported can support cash flow expectations, while a...
NYSE:LNN
NYSE:LNNMachinery

Lindsay (LNN) Rides A Stronger Infrastructure Narrative, Is The 12% Discount Enough?

Lindsay stock reaction and recent performance snapshot Lindsay (LNN) shares recently traded around $116.06, with the stock up about 1.2% over the past day and 4.7% over the past week. Returns over the past month and past 3 months were also positive. See our latest analysis for Lindsay. Short term momentum in Lindsay's share price has picked up recently, with a 7 day share price return of 4.73% and a 90 day share price return of 6.61%. However, longer term total shareholder returns over 1, 3...
NYSE:STVN
NYSE:STVNLife Sciences

How Q2 Results and Alina GLP-1 Approvals At Stevanato Group (STVN) Have Changed Its Investment Story

Stevanato Group S.p.A. recently reported past second-quarter 2026 results showing sales rising to €302 million from €280.04 million a year earlier, while net income decreased to €22.96 million and full-year 2026 guidance was slightly narrowed alongside confirming expectations for revenue of about €1.26–€1.28 billion and diluted EPS of €0.53–€0.55. A few days earlier, liraglutide-based combination products using Stevanato’s proprietary Alina variable-dose pen injector platform received...
NYSE:NVT
NYSE:NVTElectrical

nVent Electric (NVT) Is Up 7.1% After Strong Q2 Results And New AI Cooling Expansion

nVent Electric plc recently reported past second-quarter 2026 results showing sales rising to US$1,471.3 million and net income to US$215.9 million, alongside announcing a new 160,000 square-foot Blaine, Minnesota facility to expand data center liquid cooling capacity. A key insight is that this Blaine expansion marks nVent’s third data center liquid cooling capacity increase in three years, indicating a concentrated push to meet AI-driven infrastructure demand. We’ll now examine how nVent’s...
NYSE:BLX
NYSE:BLXDiversified Financial

Bladex (BLX) Could Be 13% Undervalued As Earnings And Dividend Set The Tone

Bladex earnings and dividend decision set the stage for investors Bladex (BLX) stock is back in focus after the bank reported second quarter 2026 results alongside a new quarterly dividend decision, giving investors fresh numbers on profitability and cash returns. See our latest analysis for Bladex. The latest earnings and dividend news comes after a strong period for Bladex, with the share price up 30.05% year to date and a 1 year total shareholder return of 42.66%. The recent 1 month share...
NYSE:ANF
NYSE:ANFSpecialty Retail

Is Abercrombie & Fitch’s (ANF) Fashion-First Denim Push Aligning With Its Low Forward Valuation?

Abercrombie & Fitch recently marked its Fall 2026 denim campaign with a New York event featuring style figures such as Paloma Elsesser and Emily Ratajkowski, underscoring the brand’s emphasis on fashion identity and urban roots. At the same time, investors are watching the company’s upcoming August 26, 2026 earnings release, with analyst expectations of higher revenue but lower earnings per share and a valuation that screens favorably against industry peers. Next, we will examine how...
NYSE:TGLS
NYSE:TGLSBuilding

Should Tecnoglass’s Record Q2 Revenue and Tighter 2026 Outlook Require Action From TGLS Investors?

Tecnoglass Holdings Inc. has already reported its second-quarter 2026 results, with record revenue of US$295.29 million but lower net income of US$24.56 million and diluted EPS of US$0.55 compared with the prior year, alongside narrowed full-year 2026 revenue guidance of US$1.08 billion to US$1.12 billion. Behind the headline revenue records, the company is contending with higher aluminum costs and Colombian peso strength, which, together with its recent U.S. redomiciliation and shifting...
NasdaqGS:BLLN
NasdaqGS:BLLNHealthcare

Does BillionToOne’s (BLLN) Profitability Turn and Reaffirmed 2026 Outlook Redefine Its Core Investment Story?

In August 2026, BillionToOne, Inc. reported that second-quarter 2026 sales rose to US$109.45 million with net income of US$8.05 million, and reaffirmed its full-year 2026 revenue outlook of US$450.0 million to US$465.0 million compared with 2025. The shift from a small loss to positive earnings per share across both the quarter and first half highlights a meaningful improvement in profitability alongside rapid revenue expansion. We’ll now examine how BillionToOne’s strong shift to...
NasdaqGS:KNSA
NasdaqGS:KNSABiotechs

Does Raised 2026 Revenue Guidance Change The Bull Case For Kiniksa Pharmaceuticals International (KNSA)?

Kiniksa Pharmaceuticals International, plc recently reported its second-quarter 2026 results, with revenue of US$243.6 million and net income of US$25.43 million, and raised its full-year 2026 net product revenue guidance to a range of US$980 million to US$995 million from US$930 million to US$945 million. The combination of higher guidance and year-on-year growth in revenue and earnings per share highlights management’s increased confidence in the durability of the company’s current...
NasdaqGS:ADSK
NasdaqGS:ADSKSoftware

Autodesk (ADSK) Tests Its Valuation Story After MaintainX Integration And Steady Q2 Sales

Event driven focus on Autodesk stock Autodesk (ADSK) is back in the spotlight after recent work on discounted cash flow valuation, the integration of MaintainX, and steady fiscal Q2 sales trends during restructuring, all ahead of the 27 August 2026 earnings release. See our latest analysis for Autodesk. Autodesk's recent news sits against a mixed share price backdrop, with a 19.49% 1 month share price return and 6.35% 7 day share price return, yet a year to date share price return that is...
NasdaqGS:DYN
NasdaqGS:DYNBiotechs

Dyne Therapeutics (DYN) Gets FDA Clearance With Valuation Questions Back In Focus

Dyne Therapeutics (DYN) has drawn fresh investor attention after receiving U.S. Food and Drug Administration clearance to begin a Phase 1 trial of DYNE-302 for facioscapulohumeral muscular dystrophy, a rare muscle disease without approved treatments. See our latest analysis for Dyne Therapeutics. At a share price of $26.25, Dyne Therapeutics has seen strong recent momentum, with a 30 day share price return of 12.08% and a 1 year total shareholder return of 135.22%, which suggests investor...